Retina

We ask leading experts in the field what eye disease they would cure and why.

Artificial intelligence is quickly expanding the breadth and depth of information clinicians can interpret, Prof Uy said

Timothy Lai, MD, shares promising one-year results from the SALWEEN study on faricimab for polypoidal choroidal vasculopathy at EURETINA 2025.

From lids to retina, the 2-day event on September 26 and 27, 2025, at the Margaritaville Hollywood Beach Resort, Florida, offers a collaborative and comprehensive experience with actionable takeaways.

We ask leading experts in the field what eye disease they would cure and why.

In both trials, Beacon’s lead program, laru-zova, was found to be well-tolerated by SKYLINE participants through month 36 and DAWN patients at month 9 or longer.

Roche reveals promising results for Vabysmo in treating eye diseases, showcasing significant vision improvements and safety in recent clinical trials.

The EURETINA YOURS program prepares retina specialists for the EBO exam and helps them find training in the competitive subspecialty of vitreoretinal surgery.

OCT-A angiography can help reveal early neurodegenerative disease signs, offering a non-invasive method for identifying high-risk patients through retinal analysis.

Prof Stanzel detailed new advancements in proliferative vitreoretinopathy and a hyperaspheric IOL designed for patients with age-related macular degeneration

In the debut episode of The Retina TL;DR, host Christina Y. Weng, MD, MBA, FASRS, talks with Tony Stefater, MD, PhD; and Tommy Stryjewski, MD, about PYK-2101, a biodegradable retinal sealant designed to replace gas and oil tamponades.

The start of the series that asks leading experts in the field what eye disease they would cure and why.

Discover how the International Retinal Imaging Society fosters collaboration among specialists to advance retinal imaging and transform clinical practices.

At the 2025 EURETINA Congress, Prof Korobelnik delivered the Gisbert Richard Lecture, focusing on removal of intra-ocular foreign bodies and mitigating ocular trauma.

The Vit-Buckle Symposium fosters global collaboration among eye care professionals, emphasizing interactive learning through challenging surgical case discussions.

This year's EURETINA meeting boasts a crowd of 10,000 attendees, including delegates, industry leaders, and young retina specialists.

Aleksandra Rachitskaya, MD, FASRS, is a member of the Modern Retina editorial advisory board.

Dr Ramtohul's research uses electrophysiologic testing to study the retinal ganglion cells

Roche's Contivue platform gains EU CE mark, offering innovative treatment for neovascular AMD with fewer injections and promising long-term vision outcomes.

BVI launches Virtuoso, a groundbreaking dual-function surgical platform for cataract and vitreoretinal procedures, enhancing efficiency and control in surgery.